What Is a Knee Ablation for Chronic Knee Pain?

Knee ablation, formally called genicular nerve radiofrequency ablation, is a minimally invasive procedure that uses heat to interrupt the sensory nerves carrying pain signals from an arthritic or damaged knee joint to the brain. It does not repair cartilage, fix alignment, or replace the joint. Instead, it works by denaturing the proteins inside specific nerve branches around the knee, temporarily shutting down their ability to transmit pain. The procedure has gained traction over the past decade as an option for people whose knee pain has not responded well to physical therapy, anti-inflammatory medications, or injections but who are not ready for, or not candidates for, knee replacement surgery.

How the Procedure Works

A physician inserts a thin cannula, essentially a specialized needle, through the skin and positions its tip near one of the targeted sensory nerves around the knee. The cannula delivers an intense alternating electrical field that heats the surrounding tissue. In conventional (thermal) radiofrequency ablation, the accepted heating parameters are roughly 70 to 80 degrees Celsius applied for 60 to 90 seconds per nerve site.¹ That burst of heat is enough to denature the nerve’s structural proteins and disrupt the axon’s ability to conduct signals, but it does not destroy the surrounding connective-tissue scaffolding of the nerve. This distinction matters because it allows the nerve to eventually regenerate along its original path, which is both why the procedure is considered safe and why the relief is not permanent.

Cooled radiofrequency ablation uses water-circulating electrodes that keep the cannula tip at a lower surface temperature while still generating a larger zone of thermal energy deeper in the tissue. The result is a bigger lesion, which can improve the odds of fully capturing the target nerve. A separate approach, pulsed radiofrequency, delivers short bursts of energy at temperatures below the threshold for tissue destruction, aiming to modulate nerve signaling rather than interrupt it outright.² Pulsed RF tends to be used when the physician wants to minimize tissue damage, though the evidence for its efficacy in the knee is less robust than for conventional or cooled approaches.

Which Nerves Are Targeted

The knee joint receives sensory input from a surprisingly complex web of nerves. An anatomical review found that the anterior knee alone is supplied by about ten distinct nerve branches, while the posterior knee gets input from two or three more, most commonly through a structure called the popliteal plexus.³ Yet the most commonly used ablation protocols target only three of those twelve or thirteen nerves, typically the superomedial, superolateral, and inferomedial genicular nerves. These are branches that run along bony landmarks near the femur and tibia, making them relatively straightforward to locate with imaging.

Cadaver research has mapped additional constant genicular nerves with reliable anatomic landmarks that could be targeted for treatment.⁴ The medial side of the knee, for instance, also receives branches from the saphenous nerve, the nerve to vastus medialis, and the anterior branch of the obturator nerve. The practical implication is that the standard three-nerve protocol may leave pain-carrying fibers untouched, which is one reason outcomes vary. More recent protocols that target five or more nerves appear to improve results substantially.

The Diagnostic Block Step

Before ablation, most practitioners perform a diagnostic genicular nerve block. This involves injecting a small amount of local anesthetic at each planned ablation site under image guidance. If your pain drops significantly, the reasoning is that those specific nerves are the ones responsible for your pain, and ablation at those sites should work. If it does not drop, the physician may reconsider whether ablation is the right option or whether different nerve targets are needed.

The threshold for a “successful” block varies by clinic. Some protocols require at least a 50 percent reduction in pain, while more aggressive selection criteria demand 80 percent or more. One case series that used an 80 percent threshold reported dramatic outcomes after ablation, with all patients achieving greater than 90 percent pain reduction and improved function at six months.⁵ However, diagnostic blocks carry a notable risk of false positives. The anesthetic can spread to adjacent tissues, temporarily relieving pain from structures that the ablation will not actually reach.⁶ Smaller injection volumes may reduce this problem but are still imperfect. So a positive block is encouraging but does not guarantee a successful ablation.

How Well It Works and How Long Relief Lasts

The outcome data for genicular nerve ablation are generally positive but vary depending on the timeframe and the technology used. At three months, patients in one review reported an average of 67 percent improvement from their baseline pain, with a mean pain score of about 3 out of 10.⁷ Among those who reported relief at three months, 95 percent still had meaningful pain reduction at six months, though the average improvement dipped slightly to 64 percent.

Longer follow-up studies of cooled radiofrequency ablation are particularly encouraging. In a multicenter randomized trial, 65 percent of patients in the ablation group still had at least 50 percent pain reduction at 12 months, with a mean drop of over 4 points on a 0-to-10 pain scale.⁸ An extension of that work tracked patients further: at 18 months, roughly half still maintained at least 50 percent relief, and functional improvements on standard knee questionnaires persisted through 24 months.⁹ These numbers paint a picture of a treatment that gives strong early relief that gradually fades for some patients but remains meaningful for many even beyond a year.

Who Benefits Most

Knee ablation is primarily offered to people with moderate-to-severe knee osteoarthritis who have already tried conservative approaches without adequate relief but who are poor surgical candidates due to age, other health problems, or personal preference. It is also used for patients with grade 3 or 4 osteoarthritis who fall into the gap between exhausted conservative options and total knee replacement.¹⁰

Several factors appear to predict whether the procedure will work well for a given patient. A large real-world cohort study found that people with more advanced radiographic arthritis (higher Kellgren-Lawrence grades) actually responded better than those with minimal visible joint damage. Patients whose imaging showed grade 4 disease had follow-up pain scores roughly 37 percent lower than those with little or no radiographic arthritis.¹¹ This makes intuitive sense: if the pain is clearly coming from a deteriorated joint, disrupting the nerve signals from that joint stands a good chance of helping.

Conversely, patients on baseline opioid medications or those taking antidepressants and anxiolytics had significantly worse outcomes after ablation.¹¹ Depression also independently predicted a lower likelihood of a successful response.¹² These findings suggest that centralized pain processing and mood-related amplification of pain signals may limit how much benefit a purely peripheral nerve procedure can deliver. Another strong predictor of success was targeting more than three nerves. A study using ultrasound-guided ablation found that targeting five nerves was the single most powerful predictor of a successful outcome, with over six times the odds of meaningful relief compared to fewer targets.¹²

Ablation for Pain After Knee Replacement

A less widely known application is the use of genicular nerve ablation for chronic pain after total knee replacement. Somewhere between 10 and 34 percent of people who undergo knee replacement continue to experience significant pain afterward, a frustrating situation for patients and surgeons alike. A systematic review found that ablation in this population produced a mean pain reduction of about 55 percent at three months, with minimal complications.¹³

A separate study comparing ablation outcomes in osteoarthritis patients versus post-knee-replacement patients found no meaningful difference between the two groups. About 81 percent of patients in both groups achieved at least 50 percent pain relief at three months, and around 56 percent maintained that level at six months.¹⁴ This is encouraging because chronic post-surgical knee pain has historically been difficult to treat, and having a reliable nonsurgical option is valuable. Another systematic review noted positive responses in 30 to 100 percent of post-replacement patients, though that wide range reflects the variability in study designs and patient selection criteria.¹⁵

How It Compares to Joint Injections

Many patients with knee osteoarthritis have already tried steroid injections, hyaluronic acid (viscosupplementation), or platelet-rich plasma before considering ablation. A systematic review directly comparing radiofrequency ablation to these intra-articular injection options found that ablation provided significantly better pain relief at three, six, and twelve months. Functional improvement also favored ablation over hyaluronic acid, steroid, and platelet-rich plasma injections across several outcome measures.¹⁶ The tradeoff is that ablation costs more upfront and involves a slightly more involved procedure.

On the cost-effectiveness front, a health economic analysis found that cooled radiofrequency ablation compared to steroid injections carried a cost of roughly $18,800 per quality-adjusted life year gained over six months, dropping to about $7,500 per quality-adjusted life year over 12 months.¹⁷ For context, treatments that cost less than about $50,000 per quality-adjusted life year are generally considered good value in the United States. When compared specifically to hyaluronic acid injections, cooled ablation looked more expensive at a six-month horizon but increasingly favorable at 12 months, particularly when the cost of repeat hyaluronic acid injections was factored in.¹⁸

A head-to-head trial comparing cooled to conventional radiofrequency ablation added an interesting wrinkle. For osteoarthritis pain, conventional RF actually turned out to be more cost-effective than cooled RF. But for persistent pain after knee replacement, cooled RF was dominant, meaning it cost less while delivering more benefit.¹⁹ This underscores that the best technology choice may depend on the underlying cause of the pain.

Safety and Side Effects

Genicular nerve ablation is broadly considered a low-risk procedure. The most common side effects are temporary soreness, mild swelling, or numbness around the treatment site, all of which tend to resolve within days to weeks. Serious complications are rare but have been reported. Case reports include septic arthritis (joint infection), injury to the pes anserine tendon, third-degree skin burns from probe misplacement, and significant bleeding or blood accumulation in the joint.²⁰ Because the targeted genicular nerves are purely sensory, the procedure does not cause muscle weakness or instability in the knee, which would be a serious concern if motor nerves were inadvertently hit. Modified “motor-sparing” techniques and careful imaging guidance are used specifically to avoid that risk.

The choice of imaging guidance does not appear to affect outcomes much. Both ultrasound and fluoroscopy (live X-ray) produce similar pain relief and functional improvement.²¹ The practical advantage of ultrasound is that it avoids radiation exposure entirely, which is especially relevant for patients who may need repeat procedures over years.²² Ultrasound also allows the physician to see soft-tissue structures around the nerve, potentially reducing the risk of inadvertent tendon or vascular injury.

When the Pain Comes Back

Because ablation disrupts the nerve rather than permanently destroying it, regeneration is expected. The heat damages the myelin sheath, the axon, and the inner connective tissue layer (endoneurium), but largely preserves the outer structural layers of the nerve. This is classified as a third-degree nerve injury, which is severe enough to stop signal transmission but organized enough to allow the nerve to regrow along its existing framework.²³ Alongside outright regeneration, preserved axons near the injury zone can sprout new branches and begin restoring sensation. The timeline for pain recurrence varies widely across patients, from as early as six months to well beyond a year.

The good news is that ablation can be repeated. A key clinical question is whether second or third procedures work as well as the first, or whether there are diminishing returns. Early evidence suggests that repeat ablation continues to provide meaningful relief for many patients, though the research base is still thin. If the initial ablation worked well, that is a strong indicator that future treatments at the same nerve targets will also be effective, since the underlying pain mechanism has already been confirmed.

Ablation and Opioid Use

One of the more compelling secondary benefits of knee ablation relates to opioid use. Chronic knee pain is a common reason people end up on long-term opioid prescriptions, and reducing that dependence is a goal that extends well beyond the knee. A large study found that patients who underwent genicular nerve ablation before eventually having knee replacement surgery had significantly lower odds of prolonged opioid use after the surgery, with roughly half the risk compared to patients who went straight to replacement without prior ablation.²⁴ The finding held even after accounting for other variables, and the ablation group did not experience increased surgical complications. For patients who view ablation as a bridge to eventual replacement, this opioid-sparing effect adds a meaningful secondary benefit to the pain relief itself.

It is worth noting that patients already taking opioids at the time of ablation tend to get less benefit from the procedure, as discussed earlier. This creates a practical tension: the people who might benefit most from avoiding opioids are the same ones whose outcomes from ablation are weakest if they are already on those medications. Starting ablation earlier in the pain management timeline, before chronic opioid use sets in, may give patients the best chance of a strong response and the greatest opportunity to avoid escalating to stronger pain medications.